Specifically, we evaluated their ability to distinguish moderate from severe CKD at a clinically relevant threshold of 30 mL/min/1.73 m2 and examined β2-microglobulin as a complementary biomarker whose interpretation may reflect both filtration impairment and tubular factors. Here, HLA-G is linked to chronic kidney disease.